Caristo Diagnostics Gains FDA Clearance for AI Heart Attack Prevention Tool
Caristo Diagnostics has received FDA 510(k) clearance for its AI-powered CaRi-Plaque technology, designed to aid in the diagnosis of coronary artery disease by analyzing coronary plaque.